SCHEMBL14028115

SCHEMBL14028115

CC1CCC(Cc2ccccc2)(OCCN2CCOCC2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.44
▸ DRD1 P21728 1/20 0.44
▸ DRD4 P21917 1/20 0.44
▸ DRD5 P21918 1/20 0.44
▸ SIGMAR1 Q99720 3/20 0.44
▸ ACHE P22303 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ PRCP P42785 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13503990 0.89 CYP3A4 (0.47) LTA4HDRD1DRD4DRD5SIGMAR1
SCHEMBL13503692 0.87 OPRM1 (0.45) LTA4HALDH1A1DRD1DRD4DRD5
SCHEMBL13503661 0.76 LTA4H (0.40) LTA4HDRD1DRD4DRD5SIGMAR1
SCHEMBL13681480 0.73 AQP3 (0.50) DRD1SIGMAR1POLBKDM4ECYP1A2
SCHEMBL13681482 0.72 ACHE (0.42) ALDH1A1ACHEKDM4E
SCHEMBL1111733 0.68 KDM4E (0.47) LTA4HALDH1A1DRD1DRD4DRD5
SCHEMBL3956065 0.68 KDM4E (0.47) LTA4HALDH1A1DRD1DRD4DRD5
SCHEMBL21886975 0.68 LTA4H (0.65) LTA4HALDH1A1DRD1DRD4DRD5
SCHEMBL15186974 0.66 ACHE (0.64) LTA4HALDH1A1SIGMAR1ACHEMEN1
SCHEMBL20069531 0.65 POLB (0.48) LTA4HALDH1A1DRD1DRD4DRD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7449485-B2 N-sulfonylurea apoptosis promoters ABBOTT LABORATORIES INC. (US) 2008-11-11 — — US disclosed
US-20080146572-A1 N-SULFONYLUREA APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2008-06-19 — — US disclosed
US-7358251-B2 N-sulfonylurea apoptosis promoters ABBOTT LABORATORIES (US) 2008-04-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146572-A1 N-SULFONYLUREA APOPTOSIS PROMOTERS BAX, BCL2, BAD LTA4H 3728/4885ALDH1A1 1945/4885DRD1 4769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback